Disclosure: This article was developed by United Therapeutics, the manufacturer of Orenitram, independently from the editorial content developed for Cardiology. Inclusion in this publication does not constitute a guarantee or endorsement by the American College of Cardiology (ACC), nor do statements or opinions expressed represent official ACC opinions or policies.